Irene V Lambrinoudaki

Summary

Publications

  1. Artemiadis A, Lambrinoudaki I, Voskou P, Tsivgoulis G, Safouris A, Bougea A, et al. Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy. Epilepsy Behav. 2016;55:84-6 pubmed publisher
    ..Also, LS assessments were more sensitive to these gender differences. Future larger studies should validate these results. ..
  2. Lambrinoudaki I, Kaparos G, Vlachou S, Stamatelopoulos K, Georgiopoulos G, Sergentanis T, et al. CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women. Menopause. 2008;15:1163-8 pubmed publisher
    ..It remains to be clarified whether the presence of these polymorphisms may be valuable in assessing the inherent risk among postmenopausal women. ..
  3. Lambrinoudaki I, Kaparos G, Papadimitriou D, Sergentanis T, Creatsa M, Alexandrou A, et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol. 2008;159:233-41 pubmed publisher
    ..The significance of this association with respect to the CVD risk of postmenopausal women remains to be elucidated in future studies. ..

Detail Information

Publications3

  1. Artemiadis A, Lambrinoudaki I, Voskou P, Tsivgoulis G, Safouris A, Bougea A, et al. Preliminary evidence for gender effects of levetiracetam monotherapy duration on bone health of patients with epilepsy. Epilepsy Behav. 2016;55:84-6 pubmed publisher
    ..Also, LS assessments were more sensitive to these gender differences. Future larger studies should validate these results. ..
  2. Lambrinoudaki I, Kaparos G, Vlachou S, Stamatelopoulos K, Georgiopoulos G, Sergentanis T, et al. CYP A-204C polymorphism is associated with subclinical atherosclerosis in postmenopausal women. Menopause. 2008;15:1163-8 pubmed publisher
    ..It remains to be clarified whether the presence of these polymorphisms may be valuable in assessing the inherent risk among postmenopausal women. ..
  3. Lambrinoudaki I, Kaparos G, Papadimitriou D, Sergentanis T, Creatsa M, Alexandrou A, et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol. 2008;159:233-41 pubmed publisher
    ..The significance of this association with respect to the CVD risk of postmenopausal women remains to be elucidated in future studies. ..